nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—Common cold—Pravastatin—atherosclerosis	0.0411	0.0473	CcSEcCtD
Esmolol—Ibuprofen—THBD—atherosclerosis	0.0137	0.385	CrCbGaD
Esmolol—Inflammation—Ezetimibe—atherosclerosis	0.0128	0.0148	CcSEcCtD
Esmolol—Inflammation—Simvastatin—atherosclerosis	0.0122	0.0141	CcSEcCtD
Esmolol—Skin discolouration—Niacin—atherosclerosis	0.0121	0.0139	CcSEcCtD
Esmolol—Skin exfoliation—Niacin—atherosclerosis	0.0104	0.012	CcSEcCtD
Esmolol—Neuropathy—Pravastatin—atherosclerosis	0.0101	0.0116	CcSEcCtD
Esmolol—Abnormal vision—Niacin—atherosclerosis	0.00951	0.0109	CcSEcCtD
Esmolol—Ibuprofen—PLAT—atherosclerosis	0.00938	0.264	CrCbGaD
Esmolol—Dermatitis bullous—Niacin—atherosclerosis	0.00828	0.00953	CcSEcCtD
Esmolol—Neuropathy peripheral—Rosuvastatin—atherosclerosis	0.00822	0.00945	CcSEcCtD
Esmolol—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00808	0.0093	CcSEcCtD
Esmolol—Abdominal discomfort—Lovastatin—atherosclerosis	0.00764	0.00879	CcSEcCtD
Esmolol—Rhinitis—Rosuvastatin—atherosclerosis	0.00754	0.00868	CcSEcCtD
Esmolol—Urinary retention—Niacin—atherosclerosis	0.00753	0.00866	CcSEcCtD
Esmolol—Pharyngitis—Rosuvastatin—atherosclerosis	0.00747	0.00859	CcSEcCtD
Esmolol—Abdominal discomfort—Simvastatin—atherosclerosis	0.00714	0.00822	CcSEcCtD
Esmolol—Nasopharyngitis—Pravastatin—atherosclerosis	0.00697	0.00802	CcSEcCtD
Esmolol—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00696	0.00801	CcSEcCtD
Esmolol—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00683	0.00786	CcSEcCtD
Esmolol—Angina pectoris—Niacin—atherosclerosis	0.00667	0.00767	CcSEcCtD
Esmolol—Mental disorder—Rosuvastatin—atherosclerosis	0.00659	0.00758	CcSEcCtD
Esmolol—Angina pectoris—Pravastatin—atherosclerosis	0.00656	0.00755	CcSEcCtD
Esmolol—Sweating increased—Pravastatin—atherosclerosis	0.00656	0.00755	CcSEcCtD
Esmolol—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00651	0.00749	CcSEcCtD
Esmolol—Dysuria—Pravastatin—atherosclerosis	0.0063	0.00725	CcSEcCtD
Esmolol—Pharyngitis—Ezetimibe—atherosclerosis	0.00621	0.00714	CcSEcCtD
Esmolol—Angioedema—Rosuvastatin—atherosclerosis	0.00599	0.00688	CcSEcCtD
Esmolol—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00592	0.00681	CcSEcCtD
Esmolol—Flushing—Lovastatin—atherosclerosis	0.00592	0.00681	CcSEcCtD
Esmolol—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00589	0.00677	CcSEcCtD
Esmolol—Myocardial infarction—Pravastatin—atherosclerosis	0.00589	0.00677	CcSEcCtD
Esmolol—Flushing—Ezetimibe—atherosclerosis	0.0058	0.00668	CcSEcCtD
Esmolol—Chills—Lovastatin—atherosclerosis	0.00572	0.00658	CcSEcCtD
Esmolol—Angiopathy—Ezetimibe—atherosclerosis	0.00567	0.00653	CcSEcCtD
Esmolol—Flushing—Simvastatin—atherosclerosis	0.00554	0.00637	CcSEcCtD
Esmolol—Rhinitis—Niacin—atherosclerosis	0.00549	0.00632	CcSEcCtD
Esmolol—Mental disorder—Ezetimibe—atherosclerosis	0.00548	0.0063	CcSEcCtD
Esmolol—Erythema—Ezetimibe—atherosclerosis	0.00544	0.00626	CcSEcCtD
Esmolol—Dysgeusia—Lovastatin—atherosclerosis	0.00544	0.00625	CcSEcCtD
Esmolol—Rhinitis—Pravastatin—atherosclerosis	0.00541	0.00622	CcSEcCtD
Esmolol—Confusional state—Rosuvastatin—atherosclerosis	0.00539	0.0062	CcSEcCtD
Esmolol—Pharyngitis—Pravastatin—atherosclerosis	0.00535	0.00616	CcSEcCtD
Esmolol—Chills—Simvastatin—atherosclerosis	0.00535	0.00616	CcSEcCtD
Esmolol—Visual impairment—Niacin—atherosclerosis	0.00528	0.00607	CcSEcCtD
Esmolol—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00524	0.00603	CcSEcCtD
Esmolol—Mental disorder—Simvastatin—atherosclerosis	0.00523	0.00601	CcSEcCtD
Esmolol—Visual impairment—Pravastatin—atherosclerosis	0.0052	0.00598	CcSEcCtD
Esmolol—Erythema—Simvastatin—atherosclerosis	0.00519	0.00597	CcSEcCtD
Esmolol—Dysgeusia—Simvastatin—atherosclerosis	0.00508	0.00585	CcSEcCtD
Esmolol—Flushing—Niacin—atherosclerosis	0.00508	0.00585	CcSEcCtD
Esmolol—Angioedema—Lovastatin—atherosclerosis	0.00507	0.00583	CcSEcCtD
Esmolol—Flushing—Pravastatin—atherosclerosis	0.005	0.00576	CcSEcCtD
Esmolol—Cardiac disorder—Pravastatin—atherosclerosis	0.005	0.00576	CcSEcCtD
Esmolol—Angioedema—Ezetimibe—atherosclerosis	0.00498	0.00572	CcSEcCtD
Esmolol—Angiopathy—Niacin—atherosclerosis	0.00497	0.00572	CcSEcCtD
Esmolol—Chills—Niacin—atherosclerosis	0.00491	0.00565	CcSEcCtD
Esmolol—Chills—Pravastatin—atherosclerosis	0.00484	0.00557	CcSEcCtD
Esmolol—Paraesthesia—Rosuvastatin—atherosclerosis	0.0048	0.00552	CcSEcCtD
Esmolol—Erythema—Niacin—atherosclerosis	0.00477	0.00548	CcSEcCtD
Esmolol—Angioedema—Simvastatin—atherosclerosis	0.00474	0.00546	CcSEcCtD
Esmolol—Chest pain—Lovastatin—atherosclerosis	0.00473	0.00544	CcSEcCtD
Esmolol—Anxiety—Lovastatin—atherosclerosis	0.00471	0.00542	CcSEcCtD
Esmolol—Dyspepsia—Rosuvastatin—atherosclerosis	0.00471	0.00541	CcSEcCtD
Esmolol—Chest pain—Ezetimibe—atherosclerosis	0.00464	0.00533	CcSEcCtD
Esmolol—Dry mouth—Lovastatin—atherosclerosis	0.00462	0.00532	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.0046	0.0053	CcSEcCtD
Esmolol—Dysgeusia—Pravastatin—atherosclerosis	0.0046	0.00529	CcSEcCtD
Esmolol—Pain—Rosuvastatin—atherosclerosis	0.00457	0.00526	CcSEcCtD
Esmolol—Constipation—Rosuvastatin—atherosclerosis	0.00457	0.00526	CcSEcCtD
Esmolol—Confusional state—Lovastatin—atherosclerosis	0.00457	0.00525	CcSEcCtD
Esmolol—Dry mouth—Ezetimibe—atherosclerosis	0.00453	0.00521	CcSEcCtD
Esmolol—Confusional state—Ezetimibe—atherosclerosis	0.00448	0.00515	CcSEcCtD
Esmolol—Chest pain—Simvastatin—atherosclerosis	0.00442	0.00508	CcSEcCtD
Esmolol—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00441	0.00507	CcSEcCtD
Esmolol—Anxiety—Simvastatin—atherosclerosis	0.00441	0.00507	CcSEcCtD
Esmolol—Nervous system disorder—Ezetimibe—atherosclerosis	0.00436	0.00501	CcSEcCtD
Esmolol—Angioedema—Niacin—atherosclerosis	0.00436	0.00501	CcSEcCtD
Esmolol—Ibuprofen—CXCL8—atherosclerosis	0.00432	0.121	CrCbGaD
Esmolol—Anorexia—Lovastatin—atherosclerosis	0.00432	0.00497	CcSEcCtD
Esmolol—Skin disorder—Ezetimibe—atherosclerosis	0.00432	0.00496	CcSEcCtD
Esmolol—Angioedema—Pravastatin—atherosclerosis	0.00429	0.00493	CcSEcCtD
Esmolol—Syncope—Niacin—atherosclerosis	0.00428	0.00492	CcSEcCtD
Esmolol—Confusional state—Simvastatin—atherosclerosis	0.00427	0.00491	CcSEcCtD
Esmolol—Urticaria—Rosuvastatin—atherosclerosis	0.00425	0.00489	CcSEcCtD
Esmolol—Oedema—Simvastatin—atherosclerosis	0.00424	0.00487	CcSEcCtD
Esmolol—Loss of consciousness—Niacin—atherosclerosis	0.00419	0.00482	CcSEcCtD
Esmolol—Paraesthesia—Lovastatin—atherosclerosis	0.00407	0.00468	CcSEcCtD
Esmolol—Anorexia—Simvastatin—atherosclerosis	0.00404	0.00465	CcSEcCtD
Esmolol—Dyspnoea—Lovastatin—atherosclerosis	0.00404	0.00465	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00403	0.00464	CcSEcCtD
Esmolol—Chest pain—Pravastatin—atherosclerosis	0.004	0.0046	CcSEcCtD
Esmolol—Paraesthesia—Ezetimibe—atherosclerosis	0.00399	0.00459	CcSEcCtD
Esmolol—Dyspepsia—Lovastatin—atherosclerosis	0.00399	0.00459	CcSEcCtD
Esmolol—Anxiety—Pravastatin—atherosclerosis	0.00398	0.00458	CcSEcCtD
Esmolol—Dry mouth—Niacin—atherosclerosis	0.00397	0.00457	CcSEcCtD
Esmolol—Dyspnoea—Ezetimibe—atherosclerosis	0.00396	0.00456	CcSEcCtD
Esmolol—Decreased appetite—Lovastatin—atherosclerosis	0.00394	0.00453	CcSEcCtD
Esmolol—Dyspepsia—Ezetimibe—atherosclerosis	0.00391	0.0045	CcSEcCtD
Esmolol—Fatigue—Lovastatin—atherosclerosis	0.00391	0.00449	CcSEcCtD
Esmolol—Oedema—Niacin—atherosclerosis	0.00389	0.00448	CcSEcCtD
Esmolol—Pain—Lovastatin—atherosclerosis	0.00387	0.00446	CcSEcCtD
Esmolol—Constipation—Lovastatin—atherosclerosis	0.00387	0.00446	CcSEcCtD
Esmolol—Confusional state—Pravastatin—atherosclerosis	0.00386	0.00444	CcSEcCtD
Esmolol—Decreased appetite—Ezetimibe—atherosclerosis	0.00386	0.00444	CcSEcCtD
Esmolol—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00384	0.00441	CcSEcCtD
Esmolol—Asthenia—Rosuvastatin—atherosclerosis	0.00384	0.00441	CcSEcCtD
Esmolol—Oedema—Pravastatin—atherosclerosis	0.00383	0.00441	CcSEcCtD
Esmolol—Fatigue—Ezetimibe—atherosclerosis	0.00383	0.00441	CcSEcCtD
Esmolol—Shock—Niacin—atherosclerosis	0.00383	0.0044	CcSEcCtD
Esmolol—Paraesthesia—Simvastatin—atherosclerosis	0.00381	0.00438	CcSEcCtD
Esmolol—Constipation—Ezetimibe—atherosclerosis	0.0038	0.00437	CcSEcCtD
Esmolol—Pain—Ezetimibe—atherosclerosis	0.0038	0.00437	CcSEcCtD
Esmolol—Pruritus—Rosuvastatin—atherosclerosis	0.00378	0.00435	CcSEcCtD
Esmolol—Skin disorder—Niacin—atherosclerosis	0.00378	0.00435	CcSEcCtD
Esmolol—Dyspnoea—Simvastatin—atherosclerosis	0.00378	0.00435	CcSEcCtD
Esmolol—Hyperhidrosis—Niacin—atherosclerosis	0.00376	0.00433	CcSEcCtD
Esmolol—Feeling abnormal—Lovastatin—atherosclerosis	0.00373	0.00429	CcSEcCtD
Esmolol—Dyspepsia—Simvastatin—atherosclerosis	0.00373	0.00429	CcSEcCtD
Esmolol—Anorexia—Niacin—atherosclerosis	0.00371	0.00427	CcSEcCtD
Esmolol—Hyperhidrosis—Pravastatin—atherosclerosis	0.0037	0.00426	CcSEcCtD
Esmolol—Decreased appetite—Simvastatin—atherosclerosis	0.00368	0.00424	CcSEcCtD
Esmolol—Feeling abnormal—Ezetimibe—atherosclerosis	0.00366	0.00421	CcSEcCtD
Esmolol—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00366	0.00421	CcSEcCtD
Esmolol—Fatigue—Simvastatin—atherosclerosis	0.00365	0.0042	CcSEcCtD
Esmolol—Anorexia—Pravastatin—atherosclerosis	0.00365	0.0042	CcSEcCtD
Esmolol—Hypotension—Niacin—atherosclerosis	0.00364	0.00418	CcSEcCtD
Esmolol—Pain—Simvastatin—atherosclerosis	0.00362	0.00417	CcSEcCtD
Esmolol—Constipation—Simvastatin—atherosclerosis	0.00362	0.00417	CcSEcCtD
Esmolol—Urticaria—Lovastatin—atherosclerosis	0.0036	0.00414	CcSEcCtD
Esmolol—Body temperature increased—Lovastatin—atherosclerosis	0.00358	0.00412	CcSEcCtD
Esmolol—Dizziness—Rosuvastatin—atherosclerosis	0.00354	0.00407	CcSEcCtD
Esmolol—Urticaria—Ezetimibe—atherosclerosis	0.00353	0.00406	CcSEcCtD
Esmolol—Body temperature increased—Ezetimibe—atherosclerosis	0.00351	0.00404	CcSEcCtD
Esmolol—Paraesthesia—Niacin—atherosclerosis	0.00349	0.00402	CcSEcCtD
Esmolol—Feeling abnormal—Simvastatin—atherosclerosis	0.00349	0.00402	CcSEcCtD
Esmolol—Dyspnoea—Niacin—atherosclerosis	0.00347	0.00399	CcSEcCtD
Esmolol—Somnolence—Niacin—atherosclerosis	0.00346	0.00398	CcSEcCtD
Esmolol—Paraesthesia—Pravastatin—atherosclerosis	0.00344	0.00396	CcSEcCtD
Esmolol—Dyspepsia—Niacin—atherosclerosis	0.00343	0.00394	CcSEcCtD
Esmolol—Dyspnoea—Pravastatin—atherosclerosis	0.00342	0.00393	CcSEcCtD
Esmolol—Decreased appetite—Niacin—atherosclerosis	0.00338	0.00389	CcSEcCtD
Esmolol—Dyspepsia—Pravastatin—atherosclerosis	0.00337	0.00388	CcSEcCtD
Esmolol—Urticaria—Simvastatin—atherosclerosis	0.00337	0.00387	CcSEcCtD
Esmolol—Gastrointestinal disorder—Niacin—atherosclerosis	0.00336	0.00386	CcSEcCtD
Esmolol—Body temperature increased—Simvastatin—atherosclerosis	0.00335	0.00385	CcSEcCtD
Esmolol—Headache—Rosuvastatin—atherosclerosis	0.00335	0.00385	CcSEcCtD
Esmolol—Decreased appetite—Pravastatin—atherosclerosis	0.00333	0.00383	CcSEcCtD
Esmolol—Pain—Niacin—atherosclerosis	0.00333	0.00383	CcSEcCtD
Esmolol—Fatigue—Pravastatin—atherosclerosis	0.0033	0.0038	CcSEcCtD
Esmolol—Constipation—Pravastatin—atherosclerosis	0.00328	0.00377	CcSEcCtD
Esmolol—Pain—Pravastatin—atherosclerosis	0.00328	0.00377	CcSEcCtD
Esmolol—Asthenia—Lovastatin—atherosclerosis	0.00325	0.00374	CcSEcCtD
Esmolol—Pruritus—Lovastatin—atherosclerosis	0.00321	0.00369	CcSEcCtD
Esmolol—Asthenia—Ezetimibe—atherosclerosis	0.00319	0.00367	CcSEcCtD
Esmolol—Nausea—Rosuvastatin—atherosclerosis	0.00318	0.00365	CcSEcCtD
Esmolol—Feeling abnormal—Pravastatin—atherosclerosis	0.00316	0.00363	CcSEcCtD
Esmolol—Pruritus—Ezetimibe—atherosclerosis	0.00314	0.00362	CcSEcCtD
Esmolol—Urticaria—Niacin—atherosclerosis	0.00309	0.00356	CcSEcCtD
Esmolol—Body temperature increased—Niacin—atherosclerosis	0.00308	0.00354	CcSEcCtD
Esmolol—Urticaria—Pravastatin—atherosclerosis	0.00304	0.0035	CcSEcCtD
Esmolol—Asthenia—Simvastatin—atherosclerosis	0.00304	0.0035	CcSEcCtD
Esmolol—Body temperature increased—Pravastatin—atherosclerosis	0.00303	0.00348	CcSEcCtD
Esmolol—Pruritus—Simvastatin—atherosclerosis	0.003	0.00345	CcSEcCtD
Esmolol—Dizziness—Lovastatin—atherosclerosis	0.003	0.00345	CcSEcCtD
Esmolol—Ibuprofen—PPARG—atherosclerosis	0.00299	0.0839	CrCbGaD
Esmolol—Dizziness—Ezetimibe—atherosclerosis	0.00294	0.00338	CcSEcCtD
Esmolol—Vomiting—Lovastatin—atherosclerosis	0.00288	0.00331	CcSEcCtD
Esmolol—Headache—Lovastatin—atherosclerosis	0.00284	0.00326	CcSEcCtD
Esmolol—Vomiting—Ezetimibe—atherosclerosis	0.00283	0.00325	CcSEcCtD
Esmolol—Chlorphenesin—PTGS2—atherosclerosis	0.00282	0.0793	CrCbGaD
Esmolol—Dizziness—Simvastatin—atherosclerosis	0.0028	0.00322	CcSEcCtD
Esmolol—Asthenia—Niacin—atherosclerosis	0.00279	0.00321	CcSEcCtD
Esmolol—Headache—Ezetimibe—atherosclerosis	0.00278	0.0032	CcSEcCtD
Esmolol—Pruritus—Niacin—atherosclerosis	0.00275	0.00317	CcSEcCtD
Esmolol—Asthenia—Pravastatin—atherosclerosis	0.00275	0.00316	CcSEcCtD
Esmolol—Pruritus—Pravastatin—atherosclerosis	0.00271	0.00312	CcSEcCtD
Esmolol—Vomiting—Simvastatin—atherosclerosis	0.00269	0.0031	CcSEcCtD
Esmolol—Nausea—Lovastatin—atherosclerosis	0.00269	0.0031	CcSEcCtD
Esmolol—Headache—Simvastatin—atherosclerosis	0.00265	0.00305	CcSEcCtD
Esmolol—Nausea—Ezetimibe—atherosclerosis	0.00264	0.00304	CcSEcCtD
Esmolol—Dizziness—Niacin—atherosclerosis	0.00257	0.00296	CcSEcCtD
Esmolol—Dizziness—Pravastatin—atherosclerosis	0.00253	0.00291	CcSEcCtD
Esmolol—Nausea—Simvastatin—atherosclerosis	0.00252	0.0029	CcSEcCtD
Esmolol—Vomiting—Niacin—atherosclerosis	0.00247	0.00285	CcSEcCtD
Esmolol—Headache—Niacin—atherosclerosis	0.00244	0.0028	CcSEcCtD
Esmolol—Vomiting—Pravastatin—atherosclerosis	0.00244	0.0028	CcSEcCtD
Esmolol—Headache—Pravastatin—atherosclerosis	0.0024	0.00276	CcSEcCtD
Esmolol—Nausea—Niacin—atherosclerosis	0.00231	0.00266	CcSEcCtD
Esmolol—Nausea—Pravastatin—atherosclerosis	0.00228	0.00262	CcSEcCtD
Esmolol—Ibuprofen—PTGS2—atherosclerosis	0.00126	0.0354	CrCbGaD
Esmolol—Ibuprofen—ALB—atherosclerosis	0.00112	0.0316	CrCbGaD
Esmolol—ADRB1—GPCR ligand binding—CX3CL1—atherosclerosis	0.000423	0.00445	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CX3CR1—atherosclerosis	0.000422	0.00444	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CASR—atherosclerosis	0.000422	0.00444	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CX3CL1—atherosclerosis	0.000414	0.00435	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.000409	0.00431	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.000409	0.00431	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.000406	0.00427	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—CNR2—atherosclerosis	0.000401	0.00422	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.0004	0.00421	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.0004	0.00421	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.000399	0.0042	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.000397	0.00418	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—HRH1—atherosclerosis	0.000394	0.00415	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CNR2—atherosclerosis	0.000392	0.00413	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.00039	0.00411	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—HRH1—atherosclerosis	0.000386	0.00406	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HRH1—atherosclerosis	0.000358	0.00377	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—HRH1—atherosclerosis	0.00035	0.00369	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.00035	0.00368	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.000348	0.00366	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—CCL3—atherosclerosis	0.000345	0.00363	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.000342	0.0036	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.00034	0.00358	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CCL3—atherosclerosis	0.000337	0.00355	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—CCR2—atherosclerosis	0.000312	0.00328	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—EDNRA—atherosclerosis	0.000312	0.00328	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CCR2—atherosclerosis	0.000305	0.00321	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—EDNRA—atherosclerosis	0.000305	0.00321	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—GHRL—atherosclerosis	0.000304	0.0032	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—GHRL—atherosclerosis	0.000297	0.00313	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.000295	0.0031	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.000293	0.00308	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.000289	0.00304	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.000286	0.00301	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—KNG1—atherosclerosis	0.000267	0.00281	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—AGTR1—atherosclerosis	0.000265	0.00279	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—KNG1—atherosclerosis	0.000261	0.00274	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—AGTR1—atherosclerosis	0.000259	0.00273	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CCL4—atherosclerosis	0.000259	0.00272	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—UTS2—atherosclerosis	0.000254	0.00267	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CCL4—atherosclerosis	0.000253	0.00267	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—UTS2—atherosclerosis	0.000249	0.00262	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000245	0.00258	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CASR—atherosclerosis	0.000244	0.00256	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.00024	0.00252	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CASR—atherosclerosis	0.000238	0.00251	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—UTS2—atherosclerosis	0.000231	0.00243	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CNR2—atherosclerosis	0.000227	0.00238	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000226	0.00238	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—UTS2—atherosclerosis	0.000226	0.00238	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—EDN1—atherosclerosis	0.000225	0.00236	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—CCL5—atherosclerosis	0.000223	0.00235	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CNR2—atherosclerosis	0.000222	0.00233	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000221	0.00233	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CX3CR1—atherosclerosis	0.000221	0.00233	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CASR—atherosclerosis	0.000221	0.00233	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—EDN1—atherosclerosis	0.00022	0.00231	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CCL5—atherosclerosis	0.000218	0.00229	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CX3CL1—atherosclerosis	0.000217	0.00228	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CX3CR1—atherosclerosis	0.000216	0.00228	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CASR—atherosclerosis	0.000216	0.00228	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CX3CL1—atherosclerosis	0.000212	0.00223	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HRH1—atherosclerosis	0.000212	0.00223	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HRH1—atherosclerosis	0.000207	0.00218	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CNR2—atherosclerosis	0.000206	0.00216	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000202	0.00212	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CNR2—atherosclerosis	0.000201	0.00212	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000197	0.00208	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—AGT—atherosclerosis	0.000187	0.00196	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—AGT—atherosclerosis	0.000182	0.00192	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CCL3—atherosclerosis	0.000177	0.00186	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CCR2—atherosclerosis	0.000176	0.00185	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—EDNRA—atherosclerosis	0.000176	0.00185	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CCL3—atherosclerosis	0.000173	0.00182	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—F2—atherosclerosis	0.000172	0.00181	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CCR2—atherosclerosis	0.000172	0.00181	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—EDNRA—atherosclerosis	0.000172	0.00181	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—GHRL—atherosclerosis	0.000172	0.00181	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—F2—atherosclerosis	0.000169	0.00177	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—GHRL—atherosclerosis	0.000168	0.00177	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APOA4—atherosclerosis	0.000166	0.00175	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APOA4—atherosclerosis	0.000162	0.00171	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—EDNRA—atherosclerosis	0.00016	0.00168	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CCR2—atherosclerosis	0.00016	0.00168	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000159	0.00168	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CCR2—atherosclerosis	0.000156	0.00165	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—EDNRA—atherosclerosis	0.000156	0.00165	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000156	0.00164	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—GHRL—atherosclerosis	0.000156	0.00164	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—CCL2—atherosclerosis	0.000154	0.00162	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCL4—atherosclerosis	0.000153	0.00161	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—GHRL—atherosclerosis	0.000152	0.0016	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—KNG1—atherosclerosis	0.000151	0.00159	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CCL2—atherosclerosis	0.00015	0.00158	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AGTR1—atherosclerosis	0.00015	0.00158	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCL4—atherosclerosis	0.00015	0.00157	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—KNG1—atherosclerosis	0.000147	0.00155	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000147	0.00154	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APOA2—atherosclerosis	0.000143	0.0015	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APOA2—atherosclerosis	0.00014	0.00147	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—KNG1—atherosclerosis	0.000137	0.00144	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—UTS2—atherosclerosis	0.000136	0.00143	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AGTR1—atherosclerosis	0.000136	0.00143	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—KNG1—atherosclerosis	0.000134	0.00141	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—UTS2—atherosclerosis	0.000133	0.0014	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AGTR1—atherosclerosis	0.000133	0.0014	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CX3CR1—atherosclerosis	0.000131	0.00138	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CASR—atherosclerosis	0.000131	0.00138	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CX3CL1—atherosclerosis	0.000128	0.00135	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CX3CR1—atherosclerosis	0.000128	0.00135	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CASR—atherosclerosis	0.000128	0.00135	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—EDN1—atherosclerosis	0.000127	0.00134	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CCL5—atherosclerosis	0.000126	0.00133	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CX3CL1—atherosclerosis	0.000125	0.00132	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—EDN1—atherosclerosis	0.000124	0.00131	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CCL5—atherosclerosis	0.000123	0.0013	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CNR2—atherosclerosis	0.000122	0.00128	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—CXCL8—atherosclerosis	0.000121	0.00128	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—MMP3—atherosclerosis	0.000121	0.00128	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PRKCG—atherosclerosis	0.00012	0.00126	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CNR2—atherosclerosis	0.000119	0.00125	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CXCL8—atherosclerosis	0.000119	0.00125	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—MMP3—atherosclerosis	0.000119	0.00125	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000117	0.00123	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—EDN1—atherosclerosis	0.000115	0.00121	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CCL5—atherosclerosis	0.000114	0.0012	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	0.000113	0.00119	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	0.000112	0.00118	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PRKCG—atherosclerosis	0.000109	0.00114	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—VWF—atherosclerosis	0.000108	0.00114	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APOC3—atherosclerosis	0.000108	0.00113	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LDLR—atherosclerosis	0.000107	0.00113	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	0.000106	0.00112	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—VWF—atherosclerosis	0.000106	0.00111	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AGT—atherosclerosis	0.000105	0.00111	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APOC3—atherosclerosis	0.000105	0.00111	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LDLR—atherosclerosis	0.000105	0.0011	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCL3—atherosclerosis	0.000104	0.0011	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	0.000103	0.00108	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCL3—atherosclerosis	0.000102	0.00108	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NCF1—atherosclerosis	0.0001	0.00105	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NCF1—atherosclerosis	9.79e-05	0.00103	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—F2—atherosclerosis	9.74e-05	0.00102	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AGT—atherosclerosis	9.57e-05	0.00101	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—F2—atherosclerosis	9.53e-05	0.001	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	9.45e-05	0.000994	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCR2—atherosclerosis	9.45e-05	0.000994	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CYBA—atherosclerosis	9.41e-05	0.00099	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AGT—atherosclerosis	9.36e-05	0.000985	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	9.32e-05	0.000981	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	9.24e-05	0.000973	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	9.24e-05	0.000973	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	9.21e-05	0.000969	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	9.21e-05	0.000969	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	9.21e-05	0.000969	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	9.2e-05	0.000968	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	9.12e-05	0.000959	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	9.01e-05	0.000948	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	9.01e-05	0.000948	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	9.01e-05	0.000948	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—F2—atherosclerosis	8.84e-05	0.000931	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—F2—atherosclerosis	8.65e-05	0.00091	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	8.46e-05	0.000891	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	8.28e-05	0.000871	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	8.08e-05	0.000851	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	8.03e-05	0.000845	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	7.91e-05	0.000832	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	7.88e-05	0.000829	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	7.86e-05	0.000827	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PLG—atherosclerosis	7.83e-05	0.000824	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	7.71e-05	0.000811	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PLG—atherosclerosis	7.66e-05	0.000806	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	7.41e-05	0.00078	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	7.25e-05	0.000763	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	7.16e-05	0.000754	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	7.13e-05	0.00075	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	7.01e-05	0.000737	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	6.97e-05	0.000734	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APOB—atherosclerosis	6.92e-05	0.000728	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	6.86e-05	0.000722	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	6.81e-05	0.000717	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APOB—atherosclerosis	6.77e-05	0.000712	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	6.76e-05	0.000711	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	6.71e-05	0.000706	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	6.66e-05	0.000701	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	6.61e-05	0.000696	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LPL—atherosclerosis	6.61e-05	0.000695	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LPL—atherosclerosis	6.47e-05	0.00068	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	6.43e-05	0.000676	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	6.29e-05	0.000661	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	6.26e-05	0.000659	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	6.23e-05	0.000656	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	6.12e-05	0.000644	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	6.1e-05	0.000641	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	5.79e-05	0.000609	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	5.67e-05	0.000596	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AGT—atherosclerosis	5.65e-05	0.000595	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LEP—atherosclerosis	5.54e-05	0.000583	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APOE—atherosclerosis	5.54e-05	0.000583	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AGT—atherosclerosis	5.53e-05	0.000582	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	5.49e-05	0.000578	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	5.48e-05	0.000576	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APOE—atherosclerosis	5.42e-05	0.00057	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LEP—atherosclerosis	5.42e-05	0.00057	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	5.37e-05	0.000565	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	5.36e-05	0.000564	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	5.29e-05	0.000557	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—F2—atherosclerosis	5.22e-05	0.00055	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	5.17e-05	0.000544	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—F2—atherosclerosis	5.11e-05	0.000538	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	5e-05	0.000526	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	4.89e-05	0.000515	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	4.79e-05	0.000504	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—INS—atherosclerosis	4.73e-05	0.000498	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	4.68e-05	0.000493	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	4.66e-05	0.00049	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—INS—atherosclerosis	4.63e-05	0.000487	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	4.58e-05	0.000482	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	4.55e-05	0.000479	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	4.48e-05	0.000471	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	4.35e-05	0.000457	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	4.25e-05	0.000447	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	4.15e-05	0.000437	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	4.06e-05	0.000427	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	3.68e-05	0.000387	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	3.6e-05	0.000379	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	3.56e-05	0.000374	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	3.5e-05	0.000368	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	3.48e-05	0.000366	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	3.42e-05	0.00036	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	3.33e-05	0.00035	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	3.29e-05	0.000347	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	3.26e-05	0.000343	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	3.24e-05	0.000341	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	3.23e-05	0.00034	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	3.22e-05	0.000339	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	3.17e-05	0.000333	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	3.16e-05	0.000332	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	2.99e-05	0.000315	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	2.96e-05	0.000312	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	2.92e-05	0.000308	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	2.9e-05	0.000305	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	2.83e-05	0.000298	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	2.77e-05	0.000291	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	2.74e-05	0.000289	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	2.68e-05	0.000282	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IL6—atherosclerosis	2.07e-05	0.000218	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IL6—atherosclerosis	2.02e-05	0.000213	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	1.91e-05	0.000201	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	1.87e-05	0.000196	CbGpPWpGaD
